{
 "url": "https://etfiq.com/funds/xbi/holdings/",
 "section": "funds",
 "title": "XBI Holdings: All 165 Positions (Oct 13, 2026) | ETFIQ",
 "description": "All 165 XBI holdings with weights, as of Oct 13, 2026. The top 3 are MRNA 2.46%, TWST 1.86% and NTRA 1.85%. Download the full list as a CSV.",
 "as_of": "Oct 13, 2026",
 "ticker": "XBI",
 "fund": "State Street(R) SPDR(R) S&P(R) Biotech ETF",
 "fund_page": "https://etfiq.com/funds/xbi",
 "positions": 165,
 "positions_listed_on_page": 165,
 "lead": "XBI held 165 positions as of Oct 13, 2026. Moderna Inc is the largest at 2.46%; the top 10 are 17.7% of the fund.",
 "source": {
  "name": "State Street",
  "url": "https://www.ssga.com/us/en/intermediary/library-content/products/fund-data/etfs/us/holdings-daily-us-en-xbi.xlsx",
  "document": "the issuer’s own daily file",
  "book_date": "2026-10-13",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "Moderna Inc",
   "ticker": "MRNA",
   "weight_pct": 2.461,
   "page": "https://etfiq.com/holdings/mrna/"
  },
  {
   "rank": 2,
   "holding": "Twist Bioscience Corp",
   "ticker": "TWST",
   "weight_pct": 1.861,
   "page": "https://etfiq.com/holdings/twst/"
  },
  {
   "rank": 3,
   "holding": "Natera Inc",
   "ticker": "NTRA",
   "weight_pct": 1.849,
   "page": "https://etfiq.com/holdings/ntra/"
  },
  {
   "rank": 4,
   "holding": "Iovance Biotherapeutics Inc",
   "ticker": "IOVA",
   "weight_pct": 1.704,
   "page": "https://etfiq.com/holdings/iova/"
  },
  {
   "rank": 5,
   "holding": "AbbVie Inc",
   "ticker": "ABBV",
   "weight_pct": 1.688,
   "page": "https://etfiq.com/holdings/abbv/"
  },
  {
   "rank": 6,
   "holding": "Biogen Inc",
   "ticker": "BIIB",
   "weight_pct": 1.677,
   "page": "https://etfiq.com/holdings/biib/"
  },
  {
   "rank": 7,
   "holding": "United Therapeutics Corp",
   "ticker": "UTHR",
   "weight_pct": 1.655,
   "page": "https://etfiq.com/holdings/uthr/"
  },
  {
   "rank": 8,
   "holding": "Amgen Inc",
   "ticker": "AMGN",
   "weight_pct": 1.629,
   "page": "https://etfiq.com/holdings/amgn/"
  },
  {
   "rank": 9,
   "holding": "Halozyme Therapeutics Inc",
   "ticker": "HALO",
   "weight_pct": 1.575,
   "page": "https://etfiq.com/holdings/halo/"
  },
  {
   "rank": 10,
   "holding": "Exelixis Inc",
   "ticker": "EXEL",
   "weight_pct": 1.575,
   "page": "https://etfiq.com/holdings/exel/"
  },
  {
   "rank": 11,
   "holding": "Gilead Sciences Inc",
   "ticker": "GILD",
   "weight_pct": 1.568,
   "page": "https://etfiq.com/holdings/gild/"
  },
  {
   "rank": 12,
   "holding": "TG Therapeutics Inc",
   "ticker": "TGTX",
   "weight_pct": 1.535,
   "page": "https://etfiq.com/holdings/tgtx/"
  },
  {
   "rank": 13,
   "holding": "Protagonist Therapeutics Inc",
   "ticker": "PTGX",
   "weight_pct": 1.466,
   "page": "https://etfiq.com/holdings/ptgx/"
  },
  {
   "rank": 14,
   "holding": "Regeneron Pharmaceuticals Inc",
   "ticker": "REGN",
   "weight_pct": 1.439,
   "page": "https://etfiq.com/holdings/regn/"
  },
  {
   "rank": 15,
   "holding": "Vertex Pharmaceuticals Inc",
   "ticker": "VRTX",
   "weight_pct": 1.437,
   "page": "https://etfiq.com/holdings/vrtx/"
  },
  {
   "rank": 16,
   "holding": "GRAIL Inc",
   "ticker": "GRAL",
   "weight_pct": 1.436,
   "page": "https://etfiq.com/holdings/gral/"
  },
  {
   "rank": 17,
   "holding": "Spyre Therapeutics Inc",
   "ticker": "SYRE",
   "weight_pct": 1.428,
   "page": "https://etfiq.com/holdings/syre/"
  },
  {
   "rank": 18,
   "holding": "Krystal Biotech Inc",
   "ticker": "KRYS",
   "weight_pct": 1.424,
   "page": "https://etfiq.com/holdings/krys/"
  },
  {
   "rank": 19,
   "holding": "CRISPR Therapeutics AG",
   "ticker": "CRSP",
   "weight_pct": 1.421,
   "page": "https://etfiq.com/holdings/crsp/"
  },
  {
   "rank": 20,
   "holding": "Revolution Medicines Inc",
   "ticker": "RVMD",
   "weight_pct": 1.401,
   "page": "https://etfiq.com/holdings/rvmd/"
  },
  {
   "rank": 21,
   "holding": "Vaxcyte Inc",
   "ticker": "PCVX",
   "weight_pct": 1.389,
   "page": "https://etfiq.com/holdings/pcvx/"
  },
  {
   "rank": 22,
   "holding": "PTC Therapeutics Inc",
   "ticker": "PTCT",
   "weight_pct": 1.369,
   "page": "https://etfiq.com/holdings/ptct/"
  },
  {
   "rank": 23,
   "holding": "Alkermes PLC",
   "ticker": "ALKS",
   "weight_pct": 1.351,
   "page": "https://etfiq.com/holdings/alks/"
  },
  {
   "rank": 24,
   "holding": "Neurocrine Biosciences Inc",
   "ticker": "NBIX",
   "weight_pct": 1.344,
   "page": "https://etfiq.com/holdings/nbix/"
  },
  {
   "rank": 25,
   "holding": "Alnylam Pharmaceuticals Inc",
   "ticker": "ALNY",
   "weight_pct": 1.339,
   "page": "https://etfiq.com/holdings/alny/"
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "SSI US Gov Money Market Class",
   "weight_pct": 0.055
  },
  {
   "holding": "US Dollar",
   "weight_pct": -0.0
  },
  {
   "holding": "Cash and other net assets",
   "weight_pct": -0.034
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/xbi/holdings/xbi-holdings.csv",
 "json_book": "https://etfiq.com/data/books/xbi.json",
 "markdown": "https://etfiq.com/funds/xbi/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of XBI, data as of Oct 13, 2026. https://etfiq.com/funds/xbi/holdings/"
}